Marimed (MRMD) Amortizatization of Intangibles (2019 - 2026)
Marimed (MRMD) reported Amortizatization of Intangibles of $115000.0 for Q1 2026, up 9.52% year-over-year from $105000.0 in Q1 2025, and up 105.39% quarter-over-quarter from -$2.1 million in Q4 2025.
Marimed (MRMD) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
Marimed (MRMD) has 8 years of Amortizatization of Intangibles data on file, last reported at $115000.0 in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $115000.0, up 9.52% year-over-year; the trailing twelve-month figure through Mar 2026 was -$375000.0 (down 114.0% YoY), and the FY2025 annual result was $459000.0, down 84.43% from the prior year.
- Amortizatization of Intangibles advanced to $115000.0 in Q1 2026 per MRMD's latest filing, from -$2.1 million in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $969000.0 in Q2 2025 and troughed at -$2.1 million in Q4 2025.
- A 5-year average of $415062.5 and a median of $615500.0 in 2023 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2023 and 2025: Amortizatization of Intangibles surged 892.94% in 2023, then sank 341.56% in 2025.
- A 5-year view of Amortizatization of Intangibles shows it stood at $428000.0 in 2022, then surged by 97.2% to $844000.0 in 2023, then rose by 4.62% to $883000.0 in 2024, then slumped by 341.56% to -$2.1 million in 2025, then surged by 105.39% to $115000.0 in 2026.
- Business Quant data shows MRMD's Amortizatization of Intangibles at $115000.0 in Q1 2026, -$2.1 million in Q4 2025, and $674000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 242,000.00 |
| 10 | Marimed | - | - | 15.28 Mn | 115,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 115,000.00 |
| Mar 31, 2026 | 115,000.00 |
| Dec 31, 2025 | -2.13 Mn |
| Dec 31, 2025 | -2.13 Mn |
| Sep 30, 2025 | 674,000.00 |
| Sep 30, 2025 | 674,000.00 |
| Jun 30, 2025 | 969,000.00 |
| Jun 30, 2025 | 969,000.00 |
| Mar 31, 2025 | 105,000.00 |
| Mar 31, 2025 | 105,000.00 |
| Dec 31, 2024 | 883,000.00 |
| Dec 31, 2024 | 883,000.00 |
| Sep 30, 2024 | 882,000.00 |
| Sep 30, 2024 | 882,000.00 |
| Jun 30, 2024 | 809,000.00 |
| Jun 30, 2024 | 809,000.00 |
| Mar 31, 2024 | 374,000.00 |
| Mar 31, 2024 | 374,000.00 |
| Dec 31, 2023 | 844,000.00 |
| Dec 31, 2023 | 844,000.00 |